Modulation of immune cells and Th1/Th2 cytokines in insulin-treated type 2 diabetes mellitus

African Health Sciences

Volumn 16, Issue 3, 2016, Pages 712-724

  Nekoua, Magloire Pandoua ^a   Fachinan, Rufine ^a   Atchamou, Amidou K ^a   Nouatin, Odilon ^b   Amoussou Guenou, Daniel ^c   Amoussou Guenou, Marcellin K ^d   Moutairou, Kabirou ^a   Yessoufou, Akadiri ^a  

^a UNIVERSITY OF ABOMEY CALAVI   (Benin)

^b Centre d'Etude et de Recherche sur le Paludisme Associe A la Grossesse et A l'Enfance   (Benin)

^c Centre National Hospitalier et Universitaire (CNHU)   (Benin)

^d Faculty of Health Sciences (FSS)   (Benin)

Author keywords

Immune cells; Insulin; Th1 Th2 polarization; Type 2 diabetes

Indexed keywords

GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; CYTOKINE;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INSULIN BLOOD LEVEL; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; DIABETES MELLITUS, TYPE 2; IMMUNOLOGY; INSULIN RESISTANCE; MIDDLE AGED;

ADULT; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS;

EID: 84991830650     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v16i3.11     Document Type: Article

References (50)

1. American Diabetes Association (ADA). Diagnosis and classification of Diabetes Mellitus. Diabetes Care 2008; 31: 55-60.
2. Chaker L, Falla A, van der Lee SJ, Muka T, Imo D, Jaspers L, et al. The global impact of non-communicable diseases on macro-economic productivity: a systematic review. Eur J Epidemiol 2015;30:357-95.
3. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva, World Health Organization Report, 1999 (WHO/NCD/NCS/99.2), p 65.
4. Sathyapalan T, Atkin SL. Is there a role for immune and anti-inflammatory therapy in type 2 diabetes? Minerva Endocrinol 2011; 36: 147-156.
5. Li ZZ, Liu JB, Li L, Jiao L, Chen L. Intensive therapy for diabetes throughinfluence on innate immune system. Med Hypotheses 2009; 72: 675-676 PubMed .
6. Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N, et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci U S A 2009;106:13998-14003
7. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241-1248.
8. Pickup JC, Mattock MB, Chusney GD, Burt D. NI-DDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-1292.
9. Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91:4137-43.
10. Khan NA, Yessoufou A, Kim M, Hichami A. N-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia. J Autoimmun 2006; 26:268– 277.
11. Yessoufou A, Hichami A, Besnard P, Moutairou, Khan NA. PPARα deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes mellitus: modulation of T cell differentiation. Endocrinology 2006; 147:4410-4418.
12. Yessoufou A, Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of "metabolic memory". Exp Diabetes Res. 2011;2011:218598. doi: 10.1155/2011/218598.
13. Yessoufou A, Plé A, Moutairou K, Hichami A, Khan NA. Docosahexaenoic acid reduces suppressive and migratory functions of CD4+CD25+ regulatory T-cells. J Lipid Res 2009; 50:2377-88 PubMed .
14. Baranovski BM, Freixo-Lima GS, Lewis EC, Rider P. T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-Antitrypsin. Biomed Res Int. 2015;2015:184574. doi: 10.1155/2015/184574.
15. Rengarajan J, Szabo SJ, Glimcher LH. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000; 21: 479-483.
16. Wood SC, Rao TD, Frey AB. Multidose streptozotocin induction of diabetes in BALB/cBy mice induces a T cell proliferation defect in thymocytes which is reversible by interleukin-4. Cell Immunol 1999; 192: 1-12.
17. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4 þ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16:34e8.
18. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.
19. Jagannathan-Bogdan M, McDonnell ME, Shin H, Rehman Q, Hasturk H, Apovian CM. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 2011; 186: 1162-1172.
20. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, et al. B Lymphocytes Promote Insulin Resistance through Modulation of T Lymphocytes and Production of Pathogenic IgG Antibody. Nat Med 2011; 17: 610-617.
21. Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 2011; 11: 738-749.
22. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184.
23. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010; 59: 1648-1656.
24. Deiuliis J, Shah Z, Shah N, Needleman B, Mikami D, Narula V. Visceral adipose inflammation in obesity is associated with critical alterations in T regulatory cell numbers. PLoS One 2011 Jan 26; 6(1): e16376. doi: 10.1371/journal.pone.0016376.
25. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921-929.
26. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15: 930-939.
27. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101: 455-458.
28. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
29. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003;3: 253-257. Review.
30. Groux H. An overview of regulatory T cells. Microbes Infect 2001; 3: 883-9.
31. Buckner JH, Ziegler SF. Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res Ther 2004; 6: 215-22 Review.
32. Ibikounlé M, Satoguina J, Fachinan R, Tokplonou L, Batcho W, Kindé-Gazard D, Mouahid G, Moné H, Massougbodji A, Courtin D. Epidemiology of urogenital schistosomiasis and soil-transmitted helminths among schoolchildren of Lake Nokoue areas of Sô-Ava, south Benin. J. Appl. Biosci 2013; 70:5632– 5639.
33. Ibikounlé M, Ogouyèmi-Hounto A, de Tové YS, Dansou A, Courtin D, Kindé-Gazard D, Mouahid G, Moné H, Massougbodji A. Epidemiology of urinary schistosomiasis among school children in Péhunco area, Northern Benin. Malacological survey. Bull Soc Pathol Exot 2014; 107(3):177-84.
34. Greenberg AS, McDaniel ML. Identifying the links between obesity, insulin resistance and ß-cell function: potential role of adipose- derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 2002;32: 24-34.
35. Buggage RR, Matteson DM, Shen de F, Sun B, Tuaillon N, Chan CC 2003 Effect of sex hormones on experimental autoimmune uveoretinitis (EAU). Immunol Invest 32:259-273.
36. Klein SL, Bird BH, Glass GE 2001 Sex differences in immune responses and viral shedding following Seoul virus infection in Norway rats. Am J Trop Med Hyg 65:57-63.
37. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 2005; 111:1448-1454.
38. Catalano PM, Kirwan JP, Haugel- de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003; 133: 1674-1683.
39. Farese RV, Yost TJ, Eckel RH. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 1991; 40: 214-216.
40. Scoppola A, Testa G, Frontoni S, Maddaloni E, Gambardella S, Menzinger G, et al. Effects of insulin on cholesterol synthesis in type II diabetes patients. Diabetes Care 1995; 18: 1362-1369.
41. Feitosa AC, Feitosa-Filho GS, Freitas FR, Wajchenberg BL, Maranhão RC. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment. Lipids Health Dis 2013; Feb 11;12:15. doi: 10.1186/1476-511X-12-15.
42. Muller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, et al. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 2002; 45: 805-812.
43. Zeng C, Shi X, Zhang B, Liu H, Zhang L, Ding W, et al. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl) 2012; 90(2):175 PubMed -86.
44. Xiu F, Stanojcic M, Diao L, Jeschke MG. Stress Hyperglycemia, Insulin Treatment, and InnateImmune Cells. Int J Endocrinol 2014;2014:486403. doi: 10.1155/2014/486403.
45. Sarigianni M, Bekiari E, Tsapas A. Effect of glucose and insulin on oxidized low density lipoprotein phagocytosis by human monocytes: a pilot study. Angiology 2011; 62: 163-166.
46. Wurm S, Neumeier M, Weigert J. Insulin induces monocytic CXCL8 secretion by the mitogenic signalling pathway. Cytokine 2008; 44: 185-190.
47. Dimitriadis G, Maratou E, Boutati E, Psarra K, Papasteriades C, Raptis SA. Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry. Cytometry Part A 2005; 64: 27-33.
48. DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013; 110:5133-5138.
49. Sun J, Wang J, Pefanis E, Chao J, Rothschild G, Tachibana I, et al. Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B Cells. Cell Rep 2015; 13(6):1110-1117.
50. Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol. 2011;11(2):119-30. doi: 10.1038/nri2916.